Overview
BRVE market data
Price History
BRVE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- — Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $24.61 – $32.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap —.
Company News
Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors?The Motley Fool · Aug 10, 2026, 8:15 PM
8-K filing — Braveheart Bio, Inc. (BRVE)SEC EDGAR · Aug 7, 2026, 8:14 PM
Braveheart Bio IPO Opens At $30.20/Shares; IPO Priced At $18/ShareBenzinga · Aug 6, 2026, 4:52 PM
Braveheart Bio IPO Indicating $31/Share; IPO Priced At $18/ShareBenzinga · Aug 6, 2026, 3:54 PM
Braveheart Bio IPO Indicating $31.00/Share; IPO Priced At $18/ShareBenzinga · Aug 6, 2026, 3:53 PM
Braveheart Bio IPO Indicating $25.50/Share On 310K Shares; IPO Priced At $18/ShareBenzinga · Aug 6, 2026, 2:53 PM
Braveheart Bio IPO Indicating $25/Share On 304K Shares; IPO Priced At $18/ShareBenzinga · Aug 6, 2026, 2:37 PM
Braveheart Bio IPO Indicating $25/Share On 372K Shares; IPO Priced At $18/ShareBenzinga · Aug 6, 2026, 2:23 PM
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotationBenzinga · Aug 6, 2026, 2:10 PM
Reported Earlier, Braveheart Bio Prices Upsized Initial Public Offering Of 21,250,000 Shares At $18.00 Per ShareBenzinga · Aug 6, 2026, 7:25 AM